The Company tests goodwill and indefinite-lived intangible assets for impairment annually as of December 31, or more frequently if events or circumstances indicate that the carrying amount may not be recoverable. Management also evaluates, on an ongoing basis, whether changes in business conditions or other events require interim impairment testing. During the three and nine months ended September 30, 2025 and 2024, management determined there were no triggering events or changes in circumstances that would indicate the carrying value of the Company’s goodwill is not recoverable. As such, no quantitative assessment for impairment was required. No goodwill impairment charges were recorded during each of the three and nine months ended September 30, 2025 and 2024.

As management prepares its forecast and performs its annual quantitative impairment assessment as of December 31, 2025, as of the date of these financial statements, management believes it is likely that some or all of the Company’s goodwill could be impaired as of December 31, 2025. Factors that could contribute to a potential impairment include the Company’s ability to achieve forecasted financial results, continued operating losses or cash usage resulting in lower cash and cash equivalents balances relative to prior periods, changes in discount rates or other valuation assumptions, and adverse developments in market or industry conditions.


	September 30, 2025		December 31, 2024
Domain names	$	2,034	$	2,034
Developed technology	600		600
Customer relationships	595		595
Patents	37		37
Non-compete	10		10
Licenses	4		4
Intangible assets	3,280		3,280
Less: accumulated amortization	(898)		(696)
Total intangible assets, net	$	2,382	$	2,584

Total amortization expense related to intangible assets was $0.1 million and $0.2 million for the three and nine months ended September 30, 2025, respectively, and $0.3 million and $0.7 million for the three and nine months ended September 30, 2024, respectively.